Skip to main content
Clinical Trials/NCT04014218
NCT04014218
Unknown
Phase 4

Effect of Inhalation Sedation With Sevoflurane Compared With Propofol on the Sepsis-related Acute Respiratory Distress Syndrome (ARDS) Course.

Moscow Regional Research and Clinical Institute (MONIKI)1 site in 1 country80 target enrollmentJanuary 8, 2019

Overview

Phase
Phase 4
Intervention
Inhalation Sedation
Conditions
ARDS
Sponsor
Moscow Regional Research and Clinical Institute (MONIKI)
Enrollment
80
Locations
1
Primary Endpoint
mortality
Last Updated
6 years ago

Overview

Brief Summary

Investigation of effect of inhalation sedation by administration of Sevoflurane compared with Propofol on the moderate acute respiratory distress syndrome course in mechanically ventilated patients with sepsis.

Registry
clinicaltrials.gov
Start Date
January 8, 2019
End Date
January 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Moscow Regional Research and Clinical Institute (MONIKI)
Responsible Party
Principal Investigator
Principal Investigator

Valery V. Likhvantsev, Professor

Professor, Head of Intensive Care Department Moscow Regional Clinical and Research Institute

Moscow Regional Research and Clinical Institute (MONIKI)

Eligibility Criteria

Inclusion Criteria

  • P/F Ratio 100-250
  • start of mechanical ventilation

Exclusion Criteria

  • pregnancy
  • concomitant oncological disease
  • prior psychological impairment

Arms & Interventions

Inhalation sedation

Intervention: Inhalation Sedation

Propofol

Intervention: Intravenous Sedation

Outcomes

Primary Outcomes

mortality

Time Frame: 28 days after ICU admission

28 days and in-hospital mortality

ICU Length of stay (LOS)

Time Frame: 45 days after ICU admission

Length of stay in ICU

Length of mechanical ventilation (LMV)

Time Frame: 45 days after ICU admission

Length of mechanical ventilation

Secondary Outcomes

  • event of RRT(28 days after ICU admission)
  • MACCE(28 days after ICU admission)
  • P/F Ratio(45 days after ICU admission)
  • Delirium(5 days after ICU admission)

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Inhalative Sedierung mit Sevofluran im Vergleich zu Propofol bei beatmeten, postoperativen Intensivpatienten – Einfluss auf Extubationszeiten und Aufwachverhalten, Nieren- und Leberfunktion, Hämodynamik und Kardioprotektion sowie Kostenanalyse des Sedierungsregimes - Sevo in ICDer Einsatz von Sevofluran im Vergleich zur konventionellen Sedierung mit Propofol soll in Bezug auf Sedierungsgrad unter Beatmung, Extubationszeit und Aufwachverhalten, Hämodynamik, Kardioprotektion und Nierenfunktion, sowie Kosten der Sedierung evaluiert werden.
EUCTR2006-004977-91-DEniversitätsklinikum Mannheim, Klinik für Anästhesiologie120
Active, not recruiting
Phase 1
Comparison between sedation obtained with Sevoflurane administered through inhalation and Propofol administered through intravenous infusioPreoperative-scheduled sedation in surgical patients admitted in the Intensive Care Unit (ICU) for postoperative monitoringMedDRA version: 21.1Level: LLTClassification code 10049124Term: Sedation during medical procedureSystem Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2017-003225-15-ITAZIENDA OSPEDALIERO-UNIVERSITARIA CAREGGI40
Recruiting
Phase 4
Inhalation anesthesia with sevoflurane vs intravenous anesthesia with propofol and dexmedetomidine on postoperative nausea vomiting and recovery parameters after anesthesia
CTRI/2023/08/057104Apollo Hospitals Bilaspur
Completed
Not Applicable
Cytokines and Sevoflurane During SurgeryCytokinesInflammatorySevoflurane
NCT01231477UPECLIN HC FM Botucatu Unesp30
Withdrawn
Not Applicable
Comparison of Propofol and Sevoflurane Anesthesia on the Quality of Recovery After Ambulatory Surgery in Obese PatientsQuality of Recovery
NCT05529875Jiangang Song